Back to Journals » OncoTargets and Therapy » Volume 1

Incompletely excised basal cell carcinomas: Our guidelines

Authors Longhi P, Serra MP, Robotti E

Published 2 July 2008 Volume 2008:1 Pages 1—4

DOI https://doi.org/10.2147/OTT.S3540

Review by Single-blind

Peer reviewer comments 5


P Longhi, M Paola Serra, E Robotti

Department of Plastic and Reconstructive Surgery “Ospedali Riuniti di Bergamo”, Bergamo, Italy

Abstract: A retrospective review of 982 patients treated for basal cell carcinoma (BCC) was conducted over a period of 8 years from 1996 to 2004. Of these patients, 16 presented a margin involvement. Two cohorts of patients with involved margin were identified: the group whose basal cell carcinoma was re-excised, and the “wait and see” group. Both sets of results obtained were compared, and then matched with recent international literature reviews. Re-excision is our current practice for incompletely excised tumor. However during the period examined only 36 patients of 116 with margin involvement, proceeded to re-excision, and of the remaining 80 patients just 39 were followed-up. The others were missed mainly because of the difficulty of attending follow-up consultations because of advanced age, poor general conditions, and unavailability of transport facilities. On the basis of several points, including a high number of residual tumors detected in the re-excised patients, and difficulty in maintaining diligent follow-up in the “wait and see” group, we stress the importance of considering an early re-excision in case of margin involvement (focal, lateral, or deep), to avoid a significant risk of recurrence. In this study 16 patients out of 39 in the “wait and see” group had recurrences over 8 years of follow-up; a significant number of recurrences was observed after 5 years. We therefore reserve a clinical follow-up only for patients in whom poor general health dissuades us from re-operation.

Keywords: basal cell carcinoma, excise, guidelines, tumor

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]